Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04844307 Withdrawn - COVID-19 Clinical Trials

Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups

CCPT
Start date: October 2021
Phase: N/A
Study type: Interventional

The objective of this study is to compare the effects of twice-a-day 15-minute sessions of inpatient physical therapy (PT) to the standard daily 30 minute sessions. The patient outcomes that will be evaluated will be length of stay, change in functional status, and disposition (home/acute rehab vs. subacute/LTAC/death) in patients admitted with COVID-19.

NCT ID: NCT04843722 Withdrawn - Covid19 Clinical Trials

COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

Start date: December 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1/2 study in adult healthy subjects that have previously been vaccinated with an FDA-authorized vaccine against COVID-19. This clinical trial is designed to assess the safety, efficacy, reactogenicity, and immunogenicity of hAd5-S-Fusion+N-ETSD formulated for subcutaneous, sublingual, and oral (capsule) administration.

NCT ID: NCT04842721 Withdrawn - Covid19 Clinical Trials

Effect of Hypertonic Saturated Saline Mouth Rinse on Covid-19 Virus in Vivo.

Start date: July 2021
Phase: Phase 2
Study type: Interventional

Sars-Cov2 virus is transmitted through the respiratory route and by direct contact with contaminated surfaces and subsequent contact with nasal, oral or ocular mucosa. Many studies have found that the oral cavity and specifically the saliva may be a high-risk route for SARS-CoV-2 infection. Thus, strategies reducing salivary viral load could contribute to reduce the risk of transmission. Furthermore, studies have shown that SARS-CoV persists for two days in oral mucous membranes before its diffusion to the lower respiratory tract. This offers an interesting preventive and therapeutic window of opportunity for the control of this disease. In addition, Naso-pharyngeal viral load was linked with lung disease severity in a study of 12 patients with pneumonia.**. Some current studies around the world, as listed on ClinicalTrials.gov, are testing the effect of some common mouth rinses/gargles on the Covid-19 viral load, including Chlorhexidine gluconate, Hydrogen peroxide Povidone Iodine, Saline (1.102% w/v, slightly hypertonic) and Alcohol. This study aims to test whether Prolonged Hypertonic Saline Mouth Rinse would reduce/eliminate*** the viral load in the Oro- Naso-Pharyngeal cavity, and could therefore be used as a strategy to reduce transmission risk in clinical and social settings. The investigator hypothesizes that COVID-19-positive participants who use Hypertonic Saline Prolonged Rinse treatment will have an reduction/elimination of their Covid viral load, will develop a negative Covid test 7 days after intervention completion and will improve their clinical symptoms, potentially reducing lung disease severity.

NCT ID: NCT04842331 Withdrawn - Clinical trials for COVID-19 Respiratory Infection

PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)

PREVENT
Start date: September 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This is an open label controlled household-randomised trial designed to evaluate the efficacy of RESP301 alongside standard of care ("SOC") versus SOC alone.

NCT ID: NCT04838847 Withdrawn - Covid19 Clinical Trials

A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19

Start date: October 1, 2021
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the humoral immune response to CVnCoV in elderly adults aged ≥65 years and younger adults aged 18-45 years, 14 days after the second dose administration.

NCT ID: NCT04836806 Withdrawn - Covid19 Clinical Trials

Cetirizine and Famotidine for COVID-19

Start date: August 2021
Phase: Phase 4
Study type: Interventional

This study is a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of cetirizine and famotidine in reducing the duration of symptoms in patients with COVID-19. Secondary aims are to determine if cetirizine and famotidine decrease severity and duration of symptoms, incidence of hospitalizations, ICU admissions, and death.

NCT ID: NCT04834128 Withdrawn - COVID - 19 Clinical Trials

A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19

Start date: December 13, 2021
Phase: Phase 2
Study type: Interventional

A Phase II safety and tolerability study of expanded gamma delta T cell lymphocytes (TCB008) in patients diagnosed with COVID-19.

NCT ID: NCT04830735 Withdrawn - Clinical trials for Symptomatic COVID-19 Infection Laboratory-Confirmed

Dasatinib for the Treatment of Moderate and Severe COVID-19

Start date: August 5, 2022
Phase: Phase 2
Study type: Interventional

This phase II trial investigates how well dasatinib works in treating patients with moderate and severe COVID-19. Dasatinib is a drug used to treat chronic leukemia which may help reduce the strong inflammation caused by COVID-19 that can damage the lungs or other organs.

NCT ID: NCT04828538 Withdrawn - Covid19 Clinical Trials

Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19

NUTROVID
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The NUTROVID Factorial Trials The purpose of the NUTROVID-Prevent and NUTROVID-Treat Factorial Trials is to determine whether Vitamin B Complex, Vitamin C, and Zinc; Vitamin D; and Omega3, taken at dosages approximating recommended dosages, can reduce the risk of COVID-19 infection, hospitalization, mortality.

NCT ID: NCT04821531 Withdrawn - Clinical trials for Corona Virus Infection

Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients

Start date: November 2021
Phase: N/A
Study type: Interventional

The investigators' aim is to conduct a study looking into safety and feasibility study of Covid patients participating in a self-guided exercises program while admitted to the hospital. The investigators will test 2 forms of exercise instruction, one using an exercise phone-based application, and the other a printed exercise manual.